What to expect when you take Aminosyn ii 8.5% and have Focal glomerulosclerosis?

Do you take Aminosyn ii 8.5% and have Focal glomerulosclerosis? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Aug, 15, 2018

442 reports have been studied.


Females aged 50 to 59 :

194 related reports were analyzed:

Most common symptoms:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  • 6.19% for females aged 50 (±5) who take Aminosyn ii 8.5%
Anaemia (lack of blood)
  • 8.76% for females aged 50 (±5) who take Aminosyn ii 8.5%
Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)
  • 6.19% for females aged 50 (±5) who take Aminosyn ii 8.5%
Blood glucose increased
  • 5.67% for females aged 50 (±5) who take Aminosyn ii 8.5%
Constipation
  • 7.73% for females aged 50 (±5) who take Aminosyn ii 8.5%
Cough
  • 5.15% for females aged 50 (±5) who take Aminosyn ii 8.5%
Depression
  • 6.19% for females aged 50 (±5) who take Aminosyn ii 8.5%
Diarrhea
  • 6.19% for females aged 50 (±5) who take Aminosyn ii 8.5%
Dyspnea (difficult or laboured breathing)
  • 5.15% for females aged 50 (±5) who take Aminosyn ii 8.5%
Fatigue (feeling of tiredness)
  • 7.73% for females aged 50 (±5) who take Aminosyn ii 8.5%
Fever
  • 15.46% for females aged 50 (±5) who take Aminosyn ii 8.5%
Headache (pain in head)
  • 5.15% for females aged 50 (±5) who take Aminosyn ii 8.5%
Heart palpitations (feelings or sensations that your heart is pounding or racing)
  • 5.15% for females aged 50 (±5) who take Aminosyn ii 8.5%
Hypoaesthesia (reduced sense of touch or sensation)
  • 6.19% for females aged 50 (±5) who take Aminosyn ii 8.5%
Hypokalemia (low potassium)
  • 5.15% for females aged 50 (±5) who take Aminosyn ii 8.5%
Joint pain
  • 6.19% for females aged 50 (±5) who take Aminosyn ii 8.5%
Nausea (feeling of having an urge to vomit)
  • 10.82% for females aged 50 (±5) who take Aminosyn ii 8.5%
Pain
  • 9.28% for females aged 50 (±5) who take Aminosyn ii 8.5%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  • 6.7% for females aged 50 (±5) who take Aminosyn ii 8.5%
Pleural effusion (water on the lungs)
  • 6.7% for females aged 50 (±5) who take Aminosyn ii 8.5%
Stress and anxiety
  • 8.76% for females aged 50 (±5) who take Aminosyn ii 8.5%
Thrombocytopenia (decrease of platelets in blood)
  • 6.7% for females aged 50 (±5) who take Aminosyn ii 8.5%
Weakness
  • 7.22% for females aged 50 (±5) who take Aminosyn ii 8.5%

Most common co-existing conditions:

Cancer pain
  • 9.28% for females aged 50 (±5) who take Aminosyn ii 8.5%
Constipation
  • 5.67% for females aged 50 (±5) who take Aminosyn ii 8.5%
Insomnia (sleeplessness)
  • 5.67% for females aged 50 (±5) who take Aminosyn ii 8.5%
Nausea (feeling of having an urge to vomit)
  • 7.73% for females aged 50 (±5) who take Aminosyn ii 8.5%
Pain
  • 5.67% for females aged 50 (±5) who take Aminosyn ii 8.5%
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  • 5.15% for females aged 50 (±5) who take Aminosyn ii 8.5%
back to top

Males aged 50 to 59 :

248 related reports were analyzed:

Most common symptoms:

Diarrhea
  • 6.45% for males aged 50 (±5) who take Aminosyn ii 8.5%
Fever
  • 10.89% for males aged 50 (±5) who take Aminosyn ii 8.5%
Hepatic function abnormal
  • 7.66% for males aged 50 (±5) who take Aminosyn ii 8.5%
Hypotension (abnormally low blood pressure)
  • 5.65% for males aged 50 (±5) who take Aminosyn ii 8.5%
Malignant neoplasm progression (cancer tumour came back)
  • 6.85% for males aged 50 (±5) who take Aminosyn ii 8.5%
Nausea (feeling of having an urge to vomit)
  • 10.89% for males aged 50 (±5) who take Aminosyn ii 8.5%
Thrombocytopenia (decrease of platelets in blood)
  • 5.65% for males aged 50 (±5) who take Aminosyn ii 8.5%
Weakness
  • 6.05% for males aged 50 (±5) who take Aminosyn ii 8.5%
White blood cell count decreased
  • 5.24% for males aged 50 (±5) who take Aminosyn ii 8.5%

Most common co-existing conditions:

Cancer pain
  • 10.08% for males aged 50 (±5) who take Aminosyn ii 8.5%
Constipation
  • 5.24% for males aged 50 (±5) who take Aminosyn ii 8.5%
Diarrhea
  • 5.24% for males aged 50 (±5) who take Aminosyn ii 8.5%
Hepatic neoplasm malignant (liver cancer)
  • 8.87% for males aged 50 (±5) who take Aminosyn ii 8.5%
High blood pressure
  • 5.65% for males aged 50 (±5) who take Aminosyn ii 8.5%
Pain
  • 10.89% for males aged 50 (±5) who take Aminosyn ii 8.5%
Renal cell carcinoma (a kidney cancer)
  • 5.65% for males aged 50 (±5) who take Aminosyn ii 8.5%
back to top

Related studies

aminosyn ii 8.5%

Aminosyn ii 8.5% has active ingredients of amino acids. (latest outcomes from Aminosyn ii 8.5% 1 users)

focal glomerulosclerosis

Focal glomerulosclerosis (disease that attacks the kidney's filtering system (glomeruli) causing serious scarring) has been reported by people with kidney transplant, nephrotic syndrome, immunodeficiency disorders, acne, metastases to bone (latest reports from 201 Focal glomerulosclerosis patients).

Aminosyn ii 8.5% and Focal glomerulosclerosis

Analysis tools (to study 499 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Aminosyn ii 8.5%, Focal glomerulosclerosis

Recent updates

General studies
Active Support Groups
Recent Care Guides

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.